Real world initial palliative treatment patterns and clinical outcomes in premenopausal patients with hormone receptor-positive, HER2-negative metastatic breast cancer: A study of the National Cancer Center, China
Yiqun Li(Chinese Academy of Medical Sciences & Peking Union Medical College), Binghe Xu(Chinese Academy of Medical Sciences & Peking Union Medical College), Peng Yuan(Chinese Academy of Medical Sciences & Peking Union Medical College), Hongnan Mo(Chinese Academy of Medical Sciences & Peking Union Medical College), Jiayu Wang(Second Hospital of Shandong University), Qiao Li(Guangzhou University of Chinese Medicine), Qing Li(Chinese Academy of Medical Sciences & Peking Union Medical College), Shanshan Chen(Chongqing University of Posts and Telecommunications), Yang Luo(Chongqing University of Posts and Telecommunications), Yimeng Chen(Chinese Academy of Medical Sciences & Peking Union Medical College), Zijing Wang(Qingdao University), Pin Zhang(Chinese Academy of Medical Sciences & Peking Union Medical College), Ying Fan(Hebei North University), Shaoyan Lin(Nanjing Agricultural University), Xiuwen Guan(Chinese Academy of Medical Sciences & Peking Union Medical College), Ruigang Cai(Chinese Academy of Medical Sciences & Peking Union Medical College), Fei Ma(Chinese Academy of Medical Sciences & Peking Union Medical College)
Cited by 10
Related Papers
Targeted therapeutic options and future perspectives for HER2-positive breast cancer
|Signal Transduction and Targeted Therapy|2019|406
Carbon cloth stimulates direct interspecies electron transfer in syntrophic co-cultures
|Bioresource Technology|2014|393
RNA m6A methylation participates in regulation of postnatal development of the mouse cerebellum
|Genome biology|2018|258
Safety, Activity, and Biomarkers of SHR-1210, an Anti-PD-1 Antibody, for Patients with Advanced Esophageal Carcinoma
|Clinical Cancer Research|2018|218